H. Steiger

DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development

David T. W. Jones, M Kreuz, M Tatagiba, 2019, Acta Neuropathologica Communications.

Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas

A. Straube, A. Peraud, J. Winkler, 2003, Neurology.

Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients

R. Fimmers, G. Reifenberger, W. Stummer, 2009, Clinical Cancer Research.

German-austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy

M. Engelhard, G. Brittinger, D. Huhn, 1988, Blut.

Meningioangiomatosis in a patient with progressive focal neurological deficit-case report and review of literature

K. Langen, M. Rapp, M. Sabel, 2013, British journal of neurosurgery.

Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.

M. Wolter, G. Reifenberger, D. Nam, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma - a single centre retrospective study

J. Felsberg, M. Rapp, M. Sabel, 2013, British journal of neurosurgery.